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antibody–antigen complexes Using 
Molecular Dynamics: a case study 
with Broad-spectrum, influenza a 
antibodies
William D. Lees, Lenka Stejskal, David S. Moss and Adrian J. Shepherd*
Institute of Structural and Molecular Biology, Birkbeck College, London, UK
In studying the binding of host antibodies to the surface antigens of pathogens, the 
structural and functional characterization of antibody–antigen complexes by X-ray 
crystallography and binding assay is important. However, the characterization requires 
experiments that are typically time consuming and expensive: thus, many antibody–
antigen complexes are under-characterized. For vaccine development and disease 
surveillance, it is often vital to assess the impact of amino acid substitutions on antibody 
binding. For example, are there antibody substitutions capable of improving binding 
without a loss of breadth, or antigen substitutions that lead to antigenic escape? The 
questions cannot be answered reliably from sequence variation alone, exhaustive sub-
stitution assays are usually impractical, and alanine scans provide at best an incomplete 
identification of the critical residue–residue interactions. Here, we show that, given an 
initial structure of an antibody bound to an antigen, molecular dynamics simulations 
using the energy method molecular mechanics with Generalized Born surface area (MM/
GBSA) can model the impact of single amino acid substitutions on antibody–antigen 
binding energy. We apply the technique to three broad-spectrum antibodies to influenza 
A hemagglutinin and examine both previously characterized and novel variant strains 
observed in the human population that may give rise to antigenic escape. We find that in 
some cases the impact of a substitution is local, while in others it causes a reorientation 
of the antibody with wide-ranging impact on residue–residue interactions: this explains, 
in part, why the change in chemical properties of a residue can be, on its own, a poor 
predictor of overall change in binding energy. Our estimates are in good agreement 
with experimental results—indeed, they approximate the degree of agreement between 
different experimental techniques. Simulations were performed on commodity computer 
hardware; hence, this approach has the potential to be widely adopted by those under-
taking infectious disease research. Novel aspects of this research include the application 
of MM/GBSA to investigate binding between broadly binding antibodies and a viral gly-
coprotein; the development of an approach for visualizing substrate–ligand interactions; 
and the use of experimental assay data to rescale our predictions, allowing us to make 
inferences about absolute, as well as relative, changes in binding energy.
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inTrODUcTiOn
The identification and characterization of broadly neutralizing 
antibodies (bnAbs) to highly mutable pathogens such as HIV (1) 
and influenza (2, 3) has important consequences both for treat-
ment and for vaccine development, but the structural under-
standing of antibody/antigen interactions is far from complete. 
An important area of focus is the impact on antibody binding of 
amino acid substitutions in the epitope—could mutation lead 
to escape?—or in the paratope—could binding be improved, 
without loss of breadth? Today, key residues are typically identi-
fied by means of alanine substitution assays, which determine 
ΔΔGbind, the change in the Gibbs free energy of binding caused 
by the substitution. These assays can be expensive and time 
consuming to conduct, particularly if the required antibody is 
not to hand, and can only provide a limited understanding of the 
contribution that individual residues make to the interaction. 
In particular, where exhaustive scans are conducted over the 
entire epitope, the sum of per-residue free-energy contributions 
inferred from alanine scanning is found to differ significantly 
from the wild-type (WT) free energy (4). Residues are therefore 
found to bind cooperatively, meaning that the contribution of 
individual residues is non-additive. Additionally, substitution 
assays cannot reliably identify the extent of intramolecular 
contacts. In particular, there are known examples of substitu-
tions outside such contacts that significantly affect ΔΔGbind, and 
examples of contact residues that are not identified by alanine 
substitution (5). Thus, a crystal structure of the complex remains 
necessary.
In this report, we study the binding characteristics and 
sensitivity to mutations of three bnAbs to influenza for which 
structures and binding assays exist. We demonstrate that molecu-
lar dynamics (MD) and other computational techniques, running 
on widely available computer hardware, can be used to comple-
ment experimental results in order to gain a deeper insight into 
molecular interactions and can also predict the structural and 
chemical impact of substitutions.
Broadly neutralizing antibodies to influenza A hemagglutinin 
(HA), a surface glycoprotein implicated in host cell attachment, 
challenge the conventional wisdom that the B-cell response to 
influenza must always be governed by antigenic drift, and raise 
the possibility of broad-spectrum therapeutic treatment and of 
vaccines that could confer longer lasting protection (6). Such 
bnAbs were initially thought to be rare but have now been isolated 
in many studies. Examples exist that bind both to the HA globular 
head and to the stalk. The functional mechanism of stalk-binding 
bnAbs is largely through inhibition of cell membrane fusion, 
although other mechanisms such as antibody-dependent 
cell-mediated cytotoxicity may also play a part (7). While the 
stalk-binding antibodies characterized to date arise from several 
germlines, the VH1–69 germline is frequently found, and around 
40 bnAbs arising from this germline have been described to date. 
Reported common features of these antibodies include binding 
through the heavy chain only; distinctive hydrophobic substitu-
tions in HCDR2 and tyrosine(s) in HCDR3 (8).
In this study, we use MD simulations employing the energy 
method molecular mechanics with Generalized Born surface 
area (MM/GBSA) in combination with experimental results 
published previously by other groups. We examine three stalk-
binding VH1–69 based bnAbs: CR6261, which neutralizes influ-
enza A group 1 strains (3), CR9114, which neutralizes influenza A 
group 1 and group 2 strains as well as influenza B strains (9), and 
CR8020, which neutralizes group 2 strains only (10). We compare 
predictions obtained from MM/GBSA with experimental results, 
and with a computational service, ANCHOR, which was used 
in one of the experimental studies, and which, in the examples 
we study, is found to provide useful initial results for a small 
computational cost.
Molecular mechanics with Generalized Born surface area is 
an approximate method for inferring the change in Gibbs free 
energy, ΔG, caused by substrate/ligand binding (11). The method 
uses a thermodynamic cycle to infer the solvated free energy of 
association, which we shall refer to for brevity as ΔGbind. The infer-
ence is derived from calculations of the free energy of association 
in vacuum, ΔGbind,vac, and of the solvation energy ΔGsolv of the 
ligand, receptor, and complex, using the following equation:
 ∆ = ∆ + ∆ − ∆ + ∆G G G G Gbind bind,vac solv,complex solv,ligand solv,rec( eptor )  
The calculation averages results obtained from an ensemble 
of uncorrelated snapshots, collected from an MD simulation 
of the explicitly solvated complex and its components. ΔGsolv is 
determined by solving the linearized Generalized Born equation 
(to determine the electrostatic contribution) and by a term to 
account for enthalpic and entropic hydrophobic contributions: 
these contributions are typically taken to be linearly proportional 
to the solvent-exposed surface area and are calibrated with refer-
ence to experimentally determined hydration energies of small 
molecules. As Generalized Born is an implicit solvent model, 
solvent molecules are removed from the MD snapshot before 
the calculation of ΔGsolv is performed: this avoids the otherwise 
lengthy convergence times that would be required to smooth 
the fluctuations in solvent–solvent interactions. ΔGbind,vac can be 
expressed in terms of enthalpic and entropic contributions:
 ∆ = ∆ − ∆G E Sbind,vac bind,vac bind,vacT  
In this application, we adopt the commonly used approxima-
tion that, as the overall conformations of ligand and substrate 
are not substantially affected by the substitutions tested, the con-
formational entropy change caused by a substitution, ΔΔSbind,vac, 
is negligible. As we are principally interested in ΔΔG rather than 
ΔG, we do not calculate ΔSbind,vac. Our inferred values of ΔG 
will therefore not agree with experimentally determined values: 
however, within the limits of our approximation that ΔΔSbind,vac 
≈ 0, determinations of ΔGbind may be compared in order to 
understand relative energies of interaction. ΔEbind,vac consists 
of the molecular mechanics contributions from bonded, elec-
trostatic, and van der Waals interactions, determined from the 
receptor, ligand, and complex structures elicited from the MD 
simulation. Receptor, ligand, and complex structures may be 
determined from independent simulations, or, on the assump-
tion that no significant conformational changes occur during 
binding, they may be extracted from a single trajectory of the 
complex. In our experience, the use of independent simulations 
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greatly increases convergence times as frames from the separate 
simulations are not correlated: we therefore employ a single 
trajectory in this case.
We use MM/GBSA both to infer the overall value of ΔΔGbind 
for a given complex, and to determine the pairwise ΔΔGbind 
between individual residues in the epitope and paratope through 
a calculation known as energy decomposition. In this calculation, 
the binding free energy attributable to the interaction between 
a specific pair of residues is determined, from the Generalized 
Born equation, as the sum of the electrostatic and hydrophobic 
terms (the contribution to ΔΔGbind,vac from ΔΔSbind,vac, which 
we assume, as above, to be negligible, cannot be attributed to 
individual residue pairs and is not included in the calculation). 
Although it is subject to limits of error imposed by the approxi-
mations in the calculation, the determination of these pairwise 
energies allows an understanding of the interaction that is not 
available directly from experimental methods. ΔΔGbind predicted 
by MM/GBSA is typically found to be proportional to but not 
identical to experimentally determined ΔΔG, likely as a result of 
inconsistent energy functions in the explicit and implicit solvent 
terms underlying the MM/GBSA calculation (11–13). As some 
experimental assays are available for the complexes we study, we 
use these to rescale our predictions.
Molecular dynamics has provided valuable insights into 
the structural consequences of substitutions in Ab/influenza 
HA complexes (14, 15). Molecular mechanics with Poisson–
Boltzmann surface area (MM/PBSA) and MM/GBSA have been 
used in at least one previous study to predict ΔΔGbind in an 
antibody/HA interaction that corresponded with experimental 
results (16). In this study, we develop novel interaction energy 
diagrams to facilitate such analysis and use MD in combination 
with MM/GBSA to develop insights into the binding character-
istics of broad-spectrum stalk-binding antibodies by studying a 
range of substitutions and Abs. We examine and contrast several 
substitutions in the epitope and paratope, and we apply current 
best practice in MM/GBSA calculations by monitoring sample 
correlation and convergence of results. To our knowledge, this is 
the first comparative study of broadly binding antibodies to viral 
glycoprotein using MD.
MaTerials anD MeThODs
starting structures
Starting structures, 3GBM (17), 4FQY (9), and 3SDY (10) (reso-
lutions 2.7, 5.25, and 2.85 Å, respectively) were downloaded from 
the RCSA Protein Data Bank (18). Residues in antibody loops 
remote from the epitope for which no coordinates were reported 
were modeled with MODELLER (19). Protonation states consist-
ent with physiological conditions were inferred by MolProbity 
(20). The trimeric biological construct was built in UCSF Chimera 
(21), using the author-defined biological unit, and the starting 
structure for simulation was created in AmberTools 15 tleap 
using the Amber ff12SB force field (22) and mbondi2 radius sets 
(23). Epitope substitutions were modeled in MODELLER using 
the single chain output by MolProbity, following which the same 
steps were taken to create the starting structure for simulation.
explicit solvent simulations
For explicit solvent simulations, the structure was solvated in 
a truncated octahedral box using TIP3P water molecules. Na+ 
ions were added to neutralize the molecular charge. A minimum 
distance of 20 Å was enforced between the structure and the box 
boundary, leading to boxes of volume 6 ×  106  Å3 containing a 
total of ~6 × 105 atoms. Simulations were conducted in Amber 14 
using the GPU-based simulation engine (24–26).
Both the WT structure and structures with substitutions 
underwent an initial energy minimization stage at constant 
volume, consisting of 2,000 steps of the steepest descent method, 
followed by 2,000 steps of the conjugate gradient method. This 
was followed by two relaxation steps: 100 ps at constant volume 
with backbone atoms restrained by a force equivalent to 4.0 kcal/
mol/Å during which the temperature was increased from 0 to 
50  K using a Langevin thermostat; then 2000  ps at constant 
pressure using a Monte Carlo barostat and Langevin thermostat, 
with backbone atoms restrained by a force equivalent to 1.0 kcal/
mol/Å. In this step, the temperature was increased from 50 to 
310 K in the first 500 ps and then held at 310 K for the remainder.
Following the relaxation steps, the production run was 
conducted at constant pressure using a Monte Carlo barostat. 
The initial production step consisted of a 9  ns simulation and 
was followed by 20 independent simulations of 1 ns each. These 
simulations were started with position coordinates from the 
end of the initial 9 ns simulation, but randomized velocities, in 
order to de-correlate the output from successive samples (27). A 
short-range interaction cutoff distance of 8 Å was used through-
out, and SHAKE was used to constrain hydrogens in all but the 
minimization step, allowing a 2 fs time step. iwrap was set to 1, 
wrapping atomic coordinates back into the primary box, in order 
to avoid coordinate overflow during the course of long simula-
tions. Default values were used for other modeling parameters.
Snapshots were extracted from each of the 20 independent 
simulations for further calculations. To allow time for velocities 
to settle, the first snapshot was taken after 500 ps of simulation 
time. To minimize correlation between snapshots, subsequent 
snapshots were taken at times 100 ps apart, resulting in a total of 
five snapshots being extracted from each of the 20 simulations. 
The sampling interval of 100 ps was determined by examining the 
time required for the time-dependent autocorrelation function 
[as determined by the Python function numpy.correlate (28)] to 
reduce to 0, using MM/GBSA ΔG values obtained from more 
closely sampled snapshots (Figure 1A). The entire simulation of 
a structure (29 ns of simulation) took approximately 6 days on our 
Nvidia Titan/X GPU hardware.
coordinate analysis
Analysis of simulation coordinates was performed using cpptraj 
from Amber Tools 15. The 100 snapshots were analyzed for 
atomic contacts between HA1/HA2 and the Ab variable regions 
with a distance cutoff of 3.9  Å, sufficient for the identification 
of hydrogen bonds and other hydrophobic contacts. All cor-
responding residues were added to the list of potential contact 
residues regardless of the number of snapshots in which the 
contact was observed. The approach taken here is inclusive of 
the molecular conformations observed during the simulation. 
FigUre 1 | Key metrics underlying molecular mechanics with generalized Born surface area (MM/gBsa) calculations. (a) Distribution of the correlation 
time of MM/GBSA ΔG energy estimates, calculated from 20 1 ns simulations yielding 60 snapshots. (B) Example cumulative estimate of ΔG as the number of 
samples is increased [dotted lines represent 95% confidence limits (see Analysis of MM/GBSA Calculations)]. (c) Example distribution of a mean ΔG obtained from 
10,000 samplings of the underlying dataset. (B,c) are taken from the analysis of substitution CR8020 D19N.
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Hydrogen bonds were inferred between hydrogen atoms bonded 
to nitrogen or oxygen atoms, where the donor and acceptor heavy 
atoms concerned were less than 3.35 Å apart, and the acceptor-
hydrogen-donor angle is greater than 135°. The hydrogen bond 
analysis was run over the same set of snapshots as for contact 
residues.
MM/gBsa calculations
Energy calculations were conducted using MMPBSA.py from 
Amber Tools 15 (29). In accordance with typical practice (27), 
configurations in the bound and unbound states were assumed 
to be similar, and based on this assumption, unsolvated topology 
files for the bound and unbound species were prepared from the 
explicit solvent topology using ante-MMPBSA.py. The antibody 
bound to each monomer was treated independently, meaning 
that the set of 100 snapshots resulted in a total of 300 samples 
for implicit solvent simulations. These simulations were run in 
Amber 14’s sander under the control of MMPBSA.py using the 
Generalized Born model with igb =  2 (23). In this model, the 
non-polar contribution to ΔG is calculated as 0.005  kcal/mol 
for each 1 Å2 of solvent-accessible surface area. Salt concentra-
tion was set to 0.2  M, and other parameters followed Amber’s 
defaults. Pairwise free-energy decompositions (idecomp  =  3) 
were obtained for all potential contact residues identified in 
the coordinate analysis. MM/GBSA analysis of a structure took 
approximately 6  h on a 20-core 2.5  GHz Intel Xeon E5-based 
server.
analysis of MM/gBsa calculations
The 100 ΔGbind values obtained for each of the three antibodies 
bound to the trimer were obtained via MMPBSA.py’s Python API 
and interleaved to form a single set of 300 results. Convergence 
was assessed by plotting the mean value obtained after from 10, 
20, …, 300 results (Figure 1B). To form an unbiased estimate of 
the confidence limits, the resulting dataset was resampled 10,000 
times: the confidence limits represent the range covered by 95% 
of the resulting means (Figure 1C).
As noted in the introduction, ΔΔGbind predicted by MM/
GBSA is typically found to be proportional to but not identical 
to experimentally determined ΔΔG. Predicted values from each 
simulation were therefore plotted against experimental values 
(Figure S1 in Supplementary Material). The slopes of the lines 
were used to rescale the predictions.
anchOr calculations
Structure files were uploaded to the ANCHOR server at http://
structure.pitt.edu/anchor. For Ab heavy/light chain residue pre-
dictions, Protein 1 was set to the Ab chain, and Protein 2 to each of 
the two cognate HA chains in turn: the results were then summed. 
For HA residue predictions of CR9114 and CR6261, Protein 1 was 
set to either HA1 or HA2, and Protein 2 to the Ab heavy chain. For 
CR8020, results for both Ab chains were summed.
influenza sequence Variation
The sequence variation (SNP) module of the Influenza Research 
Database (30) was used to identify the variation of human HA 
subtypes H1, H3, and H5 (approximately 18,000, 13,000, and 
450 strains, respectively) at key contact locations identified in 
this study. Precise numbers of strains compared varied from 
residue location to location depending on the extent of available 
sequences.
software
The software underlying our methods is publicly available at 
https://github.com/williamdlees/AmberUtils (doi:10.5281/zenodo. 
159170). The software streamlines the handling of substitutions; 
performs convergence limit calculations; and produces interac-
tion diagrams as used in this report.
resUlTs
epitope and Paratope Determination
Epitopes and paratopes were inferred from contact residues 
(Figure  2). The epitopes of CR6261 and CR9114 cover similar 
regions, although that of CR6261 includes an additional region 
at the C- and N-termini of HA1. This region includes HA1 38, 
glycosylated in group 2 strains, which may account for its omis-
sion from the CR9114 epitope (9). Interactions with HA1 residues 
play a stronger part in the CR6261 complex than that of CR9114, 
with HA1 S291 forming a strong hydrogen bond to HFR3 D72 
TaBle 1 | Percentage of the total ab/epitope interaction energy 
attributable to the individual regions identified in the text.
region % interaction energy
3gBM 
(cr6261,h5)
4FQY 
(cr9114,h3)
3sDY 
(cr8020,h3)
HCDR1 34 19 41
HCDR2 19 19 7
HFR3 18 22 0
HCDR3 29 40 39
LCDR2 0 0 13
HA1 head/stem interface 20 16 0
HA2 A helix 55 55 0
HA2 N-terminus 9 29 51
HA1 C- and N-termini 16 0 20
HA2 proximal β-sheet 0 0 29
FigUre 2 | averaged interactions between contact residues. Inferred hydrogen bonds are in red, other interactions in black. Line thickness is proportional to 
interaction energy. HA1 residues are indicated by *. Residue coloring reflects hydrophobicity at pH 7: red (pink) highly (slightly) hydrophobic, green neutral, blue 
hydrophilic. To ensure significance, and bearing in mind the overall confidence limits, only interactions with ΔG ≤ −1.0 kcal/mol are shown, and residues with no 
such interactions are omitted. All CDRs are in the heavy chain, except for LCDR2 in the CR8020 interface, which is explicitly marked.
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(predicted ΔGbind = −2.7  kcal/mol). In the CR9114 complex, 
interactions with the three tyrosines at CDR3 98–100 A provide 
stronger bonds to the N-terminus of HA2 than the single Y98 in 
CR6261. CR8020 binds closer to the viral membrane than the 
other two Abs. The HFR3 loop of CR8020 is not in contact with 
the antigen, but contacts are found in LCDR2 as well as the three 
HCDRs.
In CR6261 and CR9114, MM/GBSA calculations predict 
binding energy in the paratope to be evenly spread between four 
regions of contact: the three HCDRs, and a loop in HFR3 with 
the tip at locations 72–75 (Table 1). In the epitopes, residues in 
Helix A account for ~50% of the predicted binding energy: other 
regions in HA2 account for a further 30%, and ~20% is accounted 
for by residues in HA1 at the membrane-distal end of the globular 
head. In CR8020, predicted binding energy is less evenly spread 
between the CDRs than in the other two complexes, with HCDR1 
and HCDR3 accounting for 80% of the binding energy between 
them. In the epitope, approximately 50% of the predicted binding 
energy is accounted for by HA2 residues in a β-strand running 
between the membrane interface and Helix A.
comparison of Predicted ΔΔGbind with 
experimental results
In addition to WT assays, we selected seven published assays 
in which substitutions were applied to the Ab or the epitope 
(Table 2). These were taken from three different studies: Avnir 
et al. (8) used the ANCHOR server to predict key residues in the 
CR6261 HCDRs before verifying results experimentally; Ekiert 
et al. (10) grew the virus in culture with CR8020 to generate escape 
mutants, while Dreyfus et al. (9) undertook an extensive panel of 
substitution assays to examine the impact of variants seen in the 
wild. In reaching this total of seven substitutions, for reasons of 
economy and to obtain a spread of results, we excluded a further 
nine assays of CR9114/H3N2 substitutions from Dreyfus et  al. 
where ΔΔGbind was determined to be <1 kcal/mol, below the 95% 
confidence limits obtained in this study. We included one sub-
stitution, which was assayed in an H2 strain. Using MM/GBSA, 
we predicted ΔGbind for each substitution, and hence ΔΔGbind 
by comparing with the WT result. Experimental and predicted 
results are reasonably correlated (Table 2; Figure 3; Figure S1 in 
Supplementary Material). Error bars reflect the confidence limits 
in the MM/GBSA calculation, but do not reflect other sources 
FigUre 3 | experimentally derived ΔΔGbind for a range of substitutions 
compared with rescaled values predicted in this study, legend 
colored by ab: cr9114 blue, cr6261 magenta, cr8020 black.
TaBle 2 | Predictions of ΔΔGbind (relative to WT) for substitutions for which experimental values were found.
complex region substitution ΔΔGbind (kcal/mol) source
(ab, subtype) Molecular mechanics with  
generalized Born surface area
experimental
3GBM (CR6261, H5) HCDR2 F54A 2.8 ± 0.6 4.0 Avnir et al. (8)
HCDR3 Y98A 5.6 ± 0.4 5.1
4FQY (CR9114, H3) HA2 N-terminus HA2 D19N 2.0 ± 0.5 1.8 Dreyfus et al. (9)
A helix HA2 I45F 4.5 ± 0.6 4.3a
HA2 proximal β-sheet HA2 R25M −0.6 ± 0.5 0.3
HA2 G33E 0.5 ± 0.9 −0.4
3SDY (CR8020, H3) HA2 N-terminus HA2 D19N 4.4 ± 0.1 3.4 Ekiert et al. (10)
HA2 proximal β-sheet HA2 G33E 3.0 ± 0.2 3.7
Ranges for predictions represent bootstrapped 95% confidence limits. Experimental values are derived from published Kd values.
aThis assay was conducted against an H2 subtype, as discussed in the text.
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of error such as those introduced by the approximations in our 
approach and underlying inaccuracies in the force fields. The 
mean difference between predicted and experimental ΔΔGbind 
was 0.6 kcal/mol, σ = 0.4 kcal/mol, hence in this application, we 
find that the technique can predict ΔΔGbind within approximately 
1 kcal/mol.
For the alanine substitutions in the CR6261 HCDRs, ΔΔGbind 
largely reflects subtraction of the substituted side chain (Figure 4), 
although compensatory changes to the structure mitigate the 
overall reduction in binding energy. In some other cases, sub-
stitutions with a further reaching impact were observed: in the 
case of the HA2 substitution D19N in the CR9114 complex, the 
simulation suggests a change in orientation of the Ab with respect 
to HA2 Helix A, causing a ripple of stronger and weaker interac-
tions across the interface (Figure 5; Table S2 in Supplementary 
Material). An equally dispersed reaction was observed in the 
CR8020 complex with the substitution G33E. Here, a larger side 
chain is inserted into a congested region of the interface between 
the proximal region of HA2 and HCDR3. Changes to binding 
energies and residue distances in the region of the substitution 
itself were below the limits of error, but, in the MD simulation, 
the insertion is found to cause a realignment of the Ab that causes 
distances to other cognate CDRs to increase (Table 3), and this 
realignment is reflected in predicted pairwise ΔΔGbind (Figure 4).
Variability of Key residues in the ha stalk
We used MM/GBSA analysis to assess substitutions observed in 
WT strains that we considered likely to have significant impact 
on ΔGbind. In key epitope locations identified from pairwise free-
energy decompositions, we looked for variants found in at least 
five sequences deposited at http://fludb.org (Table 4), using the 
threshold of five as a protection against inaccurate sequencing 
calls or transcription errors. Notably, we found that HA2 F45 
was present in 63 H1 sequences, while HA2 N19 was present 
in 5 H3 sequences (Table S1 in Supplementary Material). The 
impact of F45 and N19 on CR9114 binding has been addressed 
experimentally and by our work above. In addition to the simu-
lations previously described, we simulated the impact of three 
novel substitutions for which assays have not previously been 
described: HA2 N49D in the CR9114/H3 complex; HA2 I45F in 
CR6261/H5; and E325R in CR8020/H3. The predicted ΔΔGbind 
associated with these three substitutions is comparable to that of 
experimentally determined escape mutants (Table 5).
correspondence with anchOr 
Predictions
The ANCHOR server at http://structure.pitt.edu/anchor/ 
provides rapid computational estimates of residue contact 
free energies, using a combination of Coulombic electrostatic 
potential and a desolvation term based on interatomic contacts, 
derived empirically from analysis of protein structures (31). As 
mentioned previously, Avnir et al. (8) used ANCHOR to identify 
highly favorable contacts in antibody structures for further 
examination. We find general correspondence between MM/
GBSA and ANCHOR in identifying such contacts (Figure  6), 
although some highly favorable contacts identified by MM/GBSA 
are not identified by ANCHOR: in particular, CR6261 CDR3 Y98 
is predicted by ANCHOR to be have a lower contact free energy 
than CDR2 F54 (−2.0 and −3.0 kcal/mol, respectively) although 
in experimental assays Y98A reduced binding significantly more 
than F54A (ΔΔGbind −5.1 and −4.0  kcal/mol). In the CR8020 
complex, ANCHOR does not predict any highly favorable 
FigUre 4 | interaction energy differences for selected substitutions. Layout and coloring are the same as for Figure 2, but here the thickness of the line 
represents the difference in interaction energy relative to the wild type. Dotted lines represent weaker interaction (reduced absolute ΔΔG) and solid lines represent 
stronger interaction. Only differences with an absolute value ≥1.0 kcal/mol are shown.
FigUre 5 | selected residues with significant ΔΔGbind in the substitution 
D19n in the cr9114/h3n2 complex (wild-type chains are in gold, 
superposed with the substituted complex in blue). HA chains are in the 
top-left corner, Ab chains bottom-right. The structure is viewed along the axis of 
Helix A, looking toward the viral membrane. The locations of selected residues 
with stronger interaction in the presence of the substitution are shown in 
highlighted in red, weaker in dark blue. The weaker interaction between HA2 N19 
and CDR3 Y100A allows the antibody’s orientation to shift anticlockwise along the 
Helix A axis, bringing CDR residues N30, N31, and N97 into closer contact with 
Helix A residues D46 and Q42. Furthermore, membrane-proximal Ab residues 
move away from Helix A, while membrane-distal residues move toward it. This 
latter adjustment weakens the interaction between HA1 K292 and FR3 D72, 
while strengthening interactions between FR3 F74 and HA1 K292, HA2 L 52.
TaBle 3 | Distances between ca atoms of selected residues, averaged 
over the final 2 ns of the initial production simulation of the cr8020 
complex, with and without the substitution g33e.
residues Distance (Å)
Wild type g33e
HA2 T32–HCDR3 Y100 5.6 5.5
HA1 E325–HCDR1 S31 6.1 9.5
HA1 Q327–HCDR2 Y53 7.0 11.4
HA2 D19–LCDR2 R53 9.9 8.6
HA2 D19–HCDR3 Y100 14.1 13.6
While the distance between the region in which the substitution is made and its 
cognate in the HCDR3 is not significantly changed by the substitution, it elicits a 
re-orientation of the Ab impacting other areas of the interface: in particular those 
interfacing with HCDR1,2 and LCDR2.
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contacts and predicts a contact free energy >−1 kcal/mol for S31 
and Y100, which are predicted by MM/GBSA as highly favorable.
DiscUssiOn
It is now possible to conduct MD simulations of large protein 
structures on widely available computer hardware, allowing the 
combinatorial complexity inherent in the study of broad-binding 
Abs to highly mutable proteins to be explored more widely 
than would be feasible through experimental techniques alone. 
Computational techniques can also cast light on the pairwise 
interactions between residues, which cannot be directly inferred 
from experimental results. In the experimental work, we cite one 
study that used surface plasmon resonance (8), while two used 
biolayer interferometry (9, 10). We have shown that the MM/
GBSA analysis can provide predictions of ΔΔGbind for antibodies 
in complex with influenza HA that are in good agreement with 
experimental results, and which approximate the accuracy with 
which biolayer interferometry can match results from surface 
plasmon resonance assays (32). We have used the technique to 
identify and explore substitutions of interest for which assay 
FigUre 6 | comparison of predictions of residue contact free energies from molecular mechanics with generalized Born surface area (MM/gBsa) 
with those of anchOr. Following Avnir et al. (8), Anchor predictions ≤−1 kcal/mol and >−3 kcal/mol are shaded amber, those ≤−3 kcal/mol are shaded red. For 
MM/GBSA, thresholds of −2 and −5 kcal/mol are used for the CR6261 and CR9114 complexes, and −5 and −10 kcal/mol for CR8020: these were found to 
provide the best correspondence between the two sets of results.
TaBle 5 | substitutions observed in wild-type strains that are predicted from assay and/or calculation to result in significant loss of binding energy.
ab epitope substitution subtype observed in Tested subtype ΔΔGbind (kcal/mol)
Molecular mechanics with generalized 
Born surface area (rescaled)
experimental
CR6261 I45F H1 (n = 63) H5 2.4 n.d.
CR9114 D19N H3 (n = 5) H3 2.0 1.8
I45F H1 (n = 63) H3 4.5 4.3a
N49D H3 (n = 5) H3 1.7 n.d.
CR8020 D19N H3 (n = 5) H3 4.5 3.4
E325R H3 (n = 5) H3 2.8 n.d.
aConducted against an H2 subtype. The substitutions for which experimental values are available were found to lead to virus escape (9, 10).
TaBle 4 | Wild-type variation at epitope locations found to be key to antibody binding.
region locations epitope consensus Variants
h1 h3 h5 h1 h3 h5
HA1 head/stem interface 291 CR6261/CR9114 S D S N NEG –
292 CR6261/CR9114 L K M FP RNQ –
HA1 C-terminus 325 CR8020 S E Q FP RDGK L
327 CR8020 Q Q E L HKP –
HA2 N-terminus 15 CR8020 T E Q G – –
19 All D D D N*EL N* –
HA2 proximal β-sheet 34 CR8020 Y Q Y – R –
HA2 A helix 42 CR6261/CR9114 Q Q Q – – –
45 CR6261/CR9114 I I I NF*V LTV –
49 CR6261/CR9114 T N T QS D*ST –
53 CR6261/CR9114 N N N Y Q –
For each complex, the five locations with highest predicted ΔΔGbind were identified for inclusion (some locations being common to more than one complex). For each identified 
location, the consensus amino acid was determined for the three subtypes shown, as well as variants exhibited by five or more human wild-type strains. Variants in bold italics were 
covered by assays in Dreyfus et al. (9). Starred variants were modeled in this study.
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results are not available. The crystal structure of the CR9114 
complex had a low resolution (5.7 Å), nevertheless we obtained 
comparable results: hence, although a structure is required for 
MM/GBSA analysis, it may in some cases be possible to work 
with structures of low resolution. The extended MD simulation 
may have served to refine the structure: alternatively, the low 
reported resolution may be attributable to flexible regions remote 
from the interface, such as the unbound light chain.
Molecular mechanics with Generalized Born surface area and 
MM/PBSA calculations embody approximations over and above 
those inherent in the MD force field, and they have been found 
more suited for some applications than for others. Several factors, 
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both in the specific method employed and in its application, may 
contribute to success in this case. In terms of the method, we 
monitor convergence and minimize convergence times using 
independent short simulations. We rescale the predicted energy 
values to take account of force field inconsistencies inherent in 
MM/GBSA, using experimentally derived assay values. In terms 
of the application, the receptor and ligand in this system are large 
molecules with relatively stable backbone structures, supporting 
the assumptions that changes in conformational entropy will not 
be significant and that the system can be appropriately modeled 
with a single set of simulations rather than with separate simula-
tions for the complex, the receptor and the ligand. Both complex 
and ligand are pure proteins, meaning that non-protein force 
fields (which are often not so well developed) are not required. 
Finally, we simulate single substitutions. Single substitutions are 
often examined in studies of bnAbs and can provide valuable 
insights into antibody development and the likelihood of escape; 
however, benchmarks of energy methods tend to focus on larger-
scale substitutions.
The assumption that changes in conformational entropy are 
negligible remains problematic and may ultimately limit applica-
tion of the technique. It is helpful in obtaining convergence as 
the entropy terms in MM/PBSA and MM/GBSA typically have 
the highest statistical uncertainty (11), but binding enthalpies 
typically do not correlate well with binding free energies, and the 
circumstances in which they do are not well understood (33). 
Changes in entropy can be difficult to determine experimentally, 
and the significance of entropy/enthalpy compensation is debated 
(34). Alchemical techniques (35), which maintain explicit solva-
tion throughout and do not require explicit calculation of entropic 
terms, may ultimately supersede MM/PBSA and MM/GBSA. 
They are not widely supported on the GPU today, although sup-
port in Amber in a forthcoming release has been announced. In 
current implementations, they do not to our knowledge support 
per-residue energy decomposition.
In this study, we have not found it necessary to consider the 
free-energy contribution from ordered water in the interface, 
which has proved important in some small molecule calcula-
tions (11). However, the relatively planar nature of epitopes (36) 
may make the treatment of explicit water less important than it 
can be with the more strongly defined cavities typical in such 
interactions. In identifying contact residues, we have considered 
hydrogen bonds and other hydrophobic contacts. Longer-range 
interactions, such as caton–pi interactions, have been identified 
in some antibody/antigen complexes (37); however, with MM/
GBSA, we did not find significant pairwise ΔΔGbind predicted 
between more distant residues in the complexes studied here.
Having identified key residues in the epitope with MM/GBSA, 
we were able to identify novel viral mutations observed in the field, 
that, based on a combination of experimental result and computa-
tional prediction, are predicted to lead to the escape of group 1 and 
group 2 strains from fusogenic inhibition by the bnAbs. We sug-
gest that, when considering the breadth of a bnAb, low-frequency 
variants should be considered. Of the variants considered in this 
study, H1 D19N, I45F, and H3 D19N were isolated in multiple 
geographic locations and across multiple influenza seasons, while 
H3 N49D strains were isolated from five patients in New York over 
the course of a single season and H3 E325R was isolated in five 
patients located in three different cities in Japan over the course 
of a single season. The diversity of origin, coupled with, in all but 
one variant, its isolation from multiple subjects in the same city 
during a single season, suggests that the substitution is viable and 
hence may have potential to become dominant if there is sufficient 
antigenic pressure from natural or vaccine-induced Abs (38, 39). 
Given the potential number of such variants, computational 
methods such as those presented here may be needed to support 
such an analysis. Likewise, when assessing vaccine response, to 
minimize the chances of escape, the depth (i.e., the number of 
elicited antibodies associated with distinct epitopes or binding 
patterns) should be considered as well as the breadth.
While in many cases the impact of an epitope or paratope 
substitution may be relatively local and isolated in effect, in other 
cases, such as CR9114 HA2 D19N and CR8020 G33E, it can have 
widespread effects that would be difficult to predict from a list of 
key residues or understand from a substitution assay result on its 
own. bnAbs appear to rely less on founder or “anchor” residues 
than more targeted Abs, having greater evenness of contribution 
across CDR locations (40). In the case of the structures studied here, 
particularly CR6261 and CR9114, we can see such evenness of cov-
erage in both the paratope and the epitope. As evenness of coverage 
increases, so does the likelihood of substitutions having complex, 
non-local impacts. Likewise, while the overall likelihood of escape 
may be minimized, the chances of a substitution in the epitope 
having a significant, albeit non-escaping, impact may increase. 
For these reasons, a thorough analysis of a broad-spectrum Ab is 
likely to be more demanding than that of a more highly targeted 
Ab, and predictions made on the basis of chemical properties or 
straightforward inferences of critical residues may not be reliable. 
While the HA stalk experiences substantially less variation than 
the globular head, the notion that it is “highly conserved” is based 
on an analysis of chemical similarity between residues (10, 17) and 
should not be taken to imply sequence or structural invariance.
Next-generation sequencing is allowing us to trace with detail 
the development of highly variable viruses and the antibodies that 
bind to them. There are no equivalently scalable approaches for 
determining antigenic development. Improvements in computer 
hardware and software make MD a credible tool to help bridge 
that gap. While MM/GBSA may over time be replaced by more 
self-consistent approaches, this study suggests that it can play a 
valuable role in binding studies today.
ANCHOR has been identified by other researchers as a tool 
that can identify key residues in an antigen/antibody complex, 
and in this work, we find reasonable overall correspondence 
between key residues identified by ANCHOR and those identi-
fied by MM/GBSA. Given that ANCHOR calculations on the 
two complexes ran in under a minute, the results are impressive, 
although some highly favorable contacts were not identified. More 
recent high-speed methods have employed multiscale methods to 
limit conformational sampling to the region in which a substitu-
tion occurs (41). Dourado and Flores (42), for example, restrict 
conformational sampling to the regions within 12 Å of a substitu-
tion. Our results suggest that, in the case of antibody interactions, 
better results might be obtained by extending sampling to cover 
the entire span of an epitope, which can exceed 45 Å (36).
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